Safety and Efficacy of SAB-185 for Non-hospitalized Adults with COVID-19: A Randomized Clinical Trial

By sjmartinez • July 20, 2024

Chew KW, Taiwo BO, Moser C, Daar ES, Wohl DA, Ritz J, Javan AC, Li JZ, Fischer W, Greninger AL, Bausch C, Luke T, Call R, Neytman G, Giganti MJ, Fletcher CV, Hughes MD, Eron JJ, Currier JS, Smith DM; ACTIV-2/A5401 Study Team. Safety and Efficacy of SAB-185 for Non-hospitalized Adults with COVID-19: A Randomized Clinical Trial. J Infect Dis. 2024 Jul 20:jiae369. doi: 10.1093/infdis/jiae369. Epub ahead of print. PMID: 39028902.

Tags: ACTIV-2, casirivimab/imdevimab, Clinical Trial, covid-19, Harbor UCLA, Infectious Diseases, outpatient treatment, polyclonal antibodies, Publications, SAB-185, transchromosomic

Heart failure and atrial fibrillation prediction from non-gated chest CT scans using AI-based cardiac chamber volumetry: an AI-CVD study within the multi-ethnic study of atherosclerosis (MESA)

Mirjalili SR, Atlas K, Reeves AP, Zhang C, Wasserthal J, Azimi A, Hashemi A, Mozafarybazargany M, Ghaffari Jolfayi A, Atlas T, Henschke CI, Yankelevitz DF,[...]

Editorial: The experimental models as a tool for studying therapeutic targets in COPD: lessons learned

Degobbi T Q S Lopes F, Vieira RP, Abbasi A. Editorial: The experimental models as a tool for studying therapeutic targets in COPD: lessons learned.[...]

Comparison of AI-enabled cardiac chambers volumetry based on non-gated chest CT scans with echocardiography: An AI-CVD study within the Multi-Ethnic Study of Atherosclerosis (MESA)

Mirjalili SR, Atlas K, Reeves AP, Zhang C, Wasserthal J, Azimi A, Hashemi A, Mozafarybazargany M, Ghaffari Jolfayi A, Atlas T, Henschke CI, Yankelevitz DF,[...]